Please use this identifier to cite or link to this item:
Title: Bioactive potential of selected actinobacterial strains against Mycobacterium tuberculosis and other clinical pathogens
Authors: Manigundan, K.
Revathy, S.
Sivarajan, A.
Anbarasu, S.
Jerrine, J.
Radhakrishnan, M.
Balagurunathan, R.
Keywords: Actinobacteria;Luciferase reporter phage assay;Mycobacterium tuberculosis;Anti-microbial activity
Issue Date: Aug-2019
Publisher: NISCAIR-CSIR, India
Abstract: Marine actinobacteria produces diverse array of metabolites with novel chemical structures with potential bioactivities. Exploring the understudied ecosystems may increase the chance of getting novel actinobacteria and new metabolites.The present study explores the bioactive potential of actinobacteria isolated from the marine ecosystem of Andaman and Nicobar Islands, Bay of Bengal, against Mycobacterium tuberculosis and other clinical pathogens. The crude extracts from 15 marine actinobacterial strains were produced through agar surface fermentation using YEME agar and extracted using ethyl acetate. The crude extracts were tested against the standard strain M. tuberculosis H37Rv, clinical drug sensitive M. tuberculosis, and MDR M. tuberculosis strains by luciferase reporter phage (LRP) assay at 500 µg/ml concentration. The anti-microbial activity against other clinical pathogens, namely, Staphylococcus aureus, Escherichia coli, Salmonella paratyphi, Klebsiellapneumoniae, Pseudomonas aeruginosa, Candida albicans, and Cryptococcusneoformans and non-tubercular mycobacteria, M. smegmatis was studied by agar plug method. Among the 15 extracts that were tested for anti-tubercular activity, the crude ethyl acetate extract of the 14 actinobacterial strains showed anti-tubercular activity against at least one of the three M. tuberculosis strains. Exceptionally, the ethyl acetate extract of strain SACC 168 inhibited all three M. tuberculosis strains tested. In anti-microbial screening, the crude extracts of eight strains showed anti-microbial activity including six strains, which were active against the non-tuberculous mycobacteria. Further purification and characterization of the active molecule from the potential extracts will pave way for the potential natural product candidate for tuberculosis and other microbial infections.
Page(s): 1307-1311
ISSN: 0975-1033 (Online); 0379-5136 (Print)
Appears in Collections:IJMS Vol.48(08) [August 2019]

Files in This Item:
File Description SizeFormat 
IJMS 48(8) 1307-1311.pdf464.99 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.